Sanofi (Euronext Paris: SAN)

174 avenue de France
75013 Paris, France (Map)
Phone: +33-1-53-77-40-00
Fax: +33-1-53-77-43-03
http://www.sanofi.com

Overview

Sanofi is out to make all the world's creatures a little healthier. The company, formerly known as Sanofi-Aventis, develops and manufactures prescription and over-the-counter drugs and vaccines for mankind and man's best friend. Sanofi's pharmaceutical division is its biggest revenue generator with top sellers that include blood thinners Plavix and Lovenox, cancer drug Taxotere, and insulin brand Lantus. US consumers will recognize at least one of the brands produced by subsidiary Chattem (Gold Bond, Icy Hot, and Selsun Blue, to name a few). Sanofi also operates Merial, one of the world's largest animal health firms. Subsidiary Sanofi Pasteur makes vaccines while its Genzyme unit makes biopharmaceuticals.

Sample Overview & History

Key Numbers from Hoover's UK

Key financials for Sanofi (Euronext Paris: SAN)

Company Type Public (Euronext Paris: SAN; NYSE: SNY [ADR])
Fiscal Year-End December
2010 Sales (mil.) £27,441.5
1-Year Sales Growth (3.7%)
2010 Net Income (mil.) £4,683.1
1-Year Net Income Growth (4.0%)
2010 Employees 101,575
1-Year Employee Growth (3.1%)
Get more Key Numbers
TIP: Understand how a company performs against its industry by reviewing Comparison Data. Column-to-column comparisons to the industry and the market are available with a Hoover's subscription.
TIP: Subscribers have access to detailed financial data (income statement, balance sheet, cash flow) for more than 500,000 public and private companies in the UK.

Key People from Hoover's UK

Key people and executives for Sanofi (Euronext Paris: SAN)

Chairman Serge Weinberg
(Subscribers see complete biographies -- view sample)
CEO and Director Christopher A. (Chris) Viehbacher
EVP and CFO Jérôme Contamine
TIP: Use Build Executive List to target decision makers by industry, geography, sales, net income, and number of employees.

Top Competitors from Hoover's UK

Top competitors of Sanofi (Euronext Paris: SAN)

There are 29 competitors for Sanofi; see more.
TIP: Analyze the Competitive Landscape to view a head-to-head comparison of a firm's profitability, operations, growth, and valuation versus that of its top three competitors.

Significant Developments

View company events at Sanofi (Euronext Paris: SAN) such as IPOs, bankruptcies, or executive changes

Event Details
Name Change Subscribers get full details --
view a sample
More Significant Developments

Industry Information from Hoover's UK

First Research Industry Profiles Extensive Industry Intelligence

Hoover's Industries

More Industry Information
TIP: Hoover's proprietary industry structure allows you to tell at-a-glance how diversified a company's operations are, and which line of business can be considered a company's primary industry.

Subsidiaries/Affiliates Covered By Hoover's UK

Subsidiaries/affiliates of Sanofi (Euronext Paris: SAN)

View more Subsidiaries/Affiliates of Sanofi
TIP: Use subsidiary and affiliate information to determine easy cross-sell and upsell opportunities within an organization or business line. Hoover's subscribers have full access to detailed Family Tree information.

Rankings from Hoover's UK

See how Sanofi (Euronext Paris: SAN) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones

  • CAC 40
  • Dow Jones Global Titans
  • Euronext 100
  • #59 in FT Global 500 (June 2011)
  • SBF 120
  • STOXX Europe 50
TIP: Hoover's subscribers have access to FT 500 and other rankings that make targeted list building easy.

Subscribers Get More!

Search Hoover's UK

View Hoover's UK Free Content

Buy A Report on Sanofi:

Sample UK Subscriber Content


Bizmology

No Christmas wrapping on toy safety reforms

by Linnea Kirgan, Jan. 2nd, 2008
Read more at Bizmology.com.


Companies That Exceed Expectations

Who's going above and beyond the status quo? Learn more about these groundbreaking companies!

Current Edition: Click Here



Small Business Expert

Presented by Comcast Business Class

Read More from the Current Edition: Performance Reviews



Copyright © 2012, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy